Paul Diaz

Track

Insider profile

Currently holds positions in Kindred Healthcare LLC and DaVita Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice Chairman of the Board Kindred Healthcare LLC March 31, 2015 -
Independent Director DaVita Inc July 31, 2007 -
Chief Executive Officer, Director Kindred Healthcare LLC May 17, 2012 - March 31, 2015
President, Chief Executive Officer, Director Kindred Healthcare LLC Jan. 1, 2004 - May 17, 2012
Paul Diaz's trades of Myriad Genetics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
455.61
Quantity 73,062
Value US$1,728,847
Transaction date
Planned sale
Price
433.51
Quantity 75,919 +41.0%
Value US$3,968,401
Transaction date
Planned sale
Price
155.86
Quantity 42,476 +21.5%
Value US$3,081,407
Transaction date
Proposed sale
Price
26.72
Quantity 15,000
Value US$400,800
Transaction date
Proposed sale
Price
25.07
Quantity 75,000
Value US$1,880,414
Transaction date
Sale
Price
25.07
Quantity 75,000 -6.6%
Value US$1,880,415
Transaction date
Sale
Price
25.21
Quantity 95,000 -7.7%
Value US$2,394,798
Transaction date
Proposed sale
Price
25.21
Quantity 95,000
Value US$2,394,799
Transaction date
Sale
Price
25.13
Quantity 57,844 -4.5%
Value US$1,453,550
Transaction date
Proposed sale
Price
25.13
Quantity 57,844
Value US$1,453,552
US DaVita Inc (DVA)
Transaction date
Sale
Price
81.61
Quantity 307 -3.0%
Value US$25,055
US DaVita Inc (DVA)
Transaction date
Sale
Price
82.16
Quantity 635 -5.8%
Value US$52,173
US DaVita Inc (DVA)
Transaction date
Sale
Price
82.26
Quantity 4,821 -30.6%
Value US$396,597
Transaction date
Purchase
Price
46.65
Quantity 4,000 +4.1%
Value US$186,600
Transaction date
Purchase
Price
46.55
Quantity 1,000 +1.0%
Value US$46,550
Transaction date
Purchase
Price
46.67
Quantity 1,000 +1.0%
Value US$46,670
Transaction date
Purchase
Price
46.69
Quantity 4,000 +4.3%
Value US$186,760
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-11 2024-10-11
PrS Proposed sale
73,062
455.61
US$1,728,847 		73,062 455.61 US$1,728,847
2024-10-11 2024-10-11
PlS Planned sale
75,919 +41.0%
433.51
US$3,968,401 		75,919 +41.0% 433.51 US$3,968,401
2024-09-12 2024-09-11
PlS Planned sale
42,476 +21.5%
155.86
US$3,081,407 		42,476 +21.5% 155.86 US$3,081,407
2024-09-11 2024-09-11
PrS Proposed sale
15,000
26.72
US$400,800 		15,000 26.72 US$400,800
2024-05-15 2024-05-15
PrS Proposed sale
75,000
25.07
US$1,880,414 		75,000 25.07 US$1,880,414
2024-05-15 2024-05-15
S Sale
75,000 -6.6%
25.07
US$1,880,415 		75,000 -6.6% 25.07 US$1,880,415
2024-05-15 2024-05-14
S Sale
95,000 -7.7%
25.21
US$2,394,798 		95,000 -7.7% 25.21 US$2,394,798
2024-05-14 2024-05-14
PrS Proposed sale
95,000
25.21
US$2,394,799 		95,000 25.21 US$2,394,799
2024-05-15 2024-05-13
S Sale
57,844 -4.5%
25.13
US$1,453,550 		57,844 -4.5% 25.13 US$1,453,550
2024-05-13 2024-05-13
PrS Proposed sale
57,844
25.13
US$1,453,552 		57,844 25.13 US$1,453,552
2020-05-19 2020-05-18
US DaVita Inc (DVA)
S Sale
307 -3.0%
81.61
US$25,055 		307 -3.0% 81.61 US$25,055
2020-05-19 2020-05-18
US DaVita Inc (DVA)
S Sale
635 -5.8%
82.16
US$52,173 		635 -5.8% 82.16 US$52,173
2020-05-19 2020-05-18
US DaVita Inc (DVA)
S Sale
4,821 -30.6%
82.26
US$396,597 		4,821 -30.6% 82.26 US$396,597
2004-05-13 2004-05-12
B Purchase
4,000 +4.1%
46.65
US$186,600 		4,000 +4.1% 46.65 US$186,600
2004-05-13 2004-05-12
B Purchase
1,000 +1.0%
46.55
US$46,550 		1,000 +1.0% 46.55 US$46,550
2004-05-13 2004-05-12
B Purchase
1,000 +1.0%
46.67
US$46,670 		1,000 +1.0% 46.67 US$46,670
2004-05-13 2004-05-12
B Purchase
4,000 +4.3%
46.69
US$186,760 		4,000 +4.3% 46.69 US$186,760